Browse > Article

Upregulation of Lipopolysaccharide-Induced Interleukin-10 by Prostaglandin $A_1$ in Mouse Peritoneal Macrophages  

Kim, Hyo-Young (Department of Microbiology, Aging-associated Vascular Disease Research Center, College of Medicine, Yeungnam University)
Kim, Jae-Ryong (Department of Biochemistry and Molecular Biology, Aging-associated Vascular Disease Research Center, College of Medicine, Yeungnam University)
Kim, Hee-Sun (Department of Microbiology, Aging-associated Vascular Disease Research Center, College of Medicine, Yeungnam University)
Publication Information
Journal of Microbiology and Biotechnology / v.18, no.6, 2008 , pp. 1170-1178 More about this Journal
Abstract
The cyclopentenone prostaglandins (cyPGs) prostaglandin $A_1$ ($PGA_1$) and 15-deoxy-${\Delta}^{12,14}$-prostaglandin $J_2$ (15d-$PGJ_2$) have been reported to exhibit antiinflammatory activity in activated monocytes/macrophages. However, the effects of these two cyPGs on the expression of cytokine genes may differ. In this study, we investigated the mechanism of action of $PGA_1$ in lipopolysaccharide (LPS)-induced expression of inter leu kin (IL)-10 mRNA in mouse peritoneal macrophages. 15d-$PGJ_2$ inhibited expression of LPS-induced IL-10, whereas $PGA_1$ increased LPS-induced IL-10 expression. This synergistic effect of $PGA_1$ on LPS-induced IL-10 expression reached a maximum as early as 2 h after simultaneous $PGA_1$ and LPS treatment ($PGA_1$/LPS), and did not require new protein synthesis. The synergistic effect of $PGA_1$ was inhibited by GW9662, a specific peroxisome proliferator-activated receptor ${\gamma}(PPAR{\gamma})$ antagonist, and Bay-11-7082, a NF-${\kappa}B$ inhibitor. The extracellular signal-regulated kinases (ERK) inhibitor PD98059 increased the expression of $PGA_1$/LPS-induced IL-10 mRNA, rather than inhibiting the IL-10 expression. Moreover, $PGA_1$ inhibited LPS-induced ERK phosphorylation. The synergistic effect of $PGA_1$ on LPS-induced IL-10 mRNA and protein production was inhibited by p38 inhibitor PD169316, and $PGA_1$ increased LPS-induced p38 phosphorylation. In the case of stress-activated protein kinase/c-Jun $NH_2$-terminal kinase (SAPK/JNK), the SAPK/JNK inhibitor SP600125 did not inhibit IL-10 mRNA synthesis but inhibited the production of IL-10 protein remarkably. These results suggest that the synergistic effect of $PGA_1$ on LPS-induced IL-10 expression is NF-${\kappa}B$-dependent and mediated by mitogen-activated protein (MAP) kinases, p38, and SAPK/JNK signaling pathways, and also associated with the $PPAR{\gamma}$ pathway. Our data may provide more insight into the diverse mechanisms of $PGA_1$ effects on the expression of cytokine genes.
Keywords
IL-10; macrophage; null;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
Times Cited By Web Of Science : 3  (Related Records In Web of Science)
연도 인용수 순위
1 Fu, Y., N. Luo, and M. F. Lopes-Virella. 2002. Upregulation of interleukin-8 expression by prostaglandin $J_2$ $(15d-PGJ_2)$ in human THP-1 macrophages. Atherosclerosis 160: 11-20   DOI   ScienceOn
2 Kelly, G., B. Robert, R. Chris, G. Gary, H. Perry, and C. James. 2001. Differential effects of 15-deoxy-$\Delta^{12.14}$-prostaglandin $J_2$ and a peroxisome proliferator-activated receptor $\gamma$ agonist on macrophage activation. J. Leukoc. Biol. 69: 631-638
3 Kim, J. E., H. J. Hur, K. W. Lee, and H. J. Lee. 2007. Antiinflammatory effects of recombinant arginine deiminase originating from Lactococcus lactis ssp. lactis ATCC 7962. J. Microbiol. Biotechnol. 17: 1491-1497   과학기술학회마을
4 Marx, N., F. Mach, A. Sauty, J. H. Leung, M. N. Sarafi, R. M. Randohoff, P. Libby, J. Plutzky, and A. D. Luster. 2000. Peroxisome proliferator-activated receptor-${\gamma}$ activators inhibit IFN-$\gamma$-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J. Immunol. 164: 6503-6508   DOI
5 Rossi, A., G. Elia, and M. G. Santoro. 1997. Inhibition of nuclear factor $\kappa$B by prostaglandin A1: An effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. USA 94: 746-750
6 Wilmer, W. A., C. Dixon, L. Lu, T. Hilbelink, and B. H. Rovin. 2001. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPAR$\gamma$ . Biochem. Biophys. Res.Commun. 281: 57-62   DOI   ScienceOn
7 Zhang, X., J. M. Wang, W. H. Gong, N. Mukaida, and H. A. Young. 2001. Differential regulation of chemokine gene expression by 15-deoxy-$\Delta^{12,\;14}$-prostaglandin $J_2$ . J. Immunol. 166: 7104-7111   DOI
8 Ricote, M., J. T. Huang, J. S. Welch, and C. K. Glass. 1999. The peroxisome proliferator-activated receptor $\gamma$ (PPAR$\gamma$) as a regulator of monocyte/macrophage function. J. Leukoc. Biol. 66: 733-739   DOI
9 Masamune, A., K. Kikuta, M. Satoh, Y. Sakai, A. Satoh, and T. Shimosegawa. 2002. Ligands of peroxisome proliferator activated receptor-$\gamma$ block activation of pancreatic stellate cells. J. Biol. Chem. 277: 141-147   DOI   ScienceOn
10 Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-$\gamma$ is a negative regulator of macrophage activation. Nature 391: 79- 82   DOI   ScienceOn
11 Sawano, H., M. Haneda, T. Sugimoto, K. Inoki, D. Koya, and R. Kikkawa. 2002. 15-Deoxy-$\Delta^{12,\;14}$-prostaglandin $J_2$ inhibits IL- 1$\beta$-induced cyclooxygenase-2 expression in mesangial cells. Kidney Int. 61: 1957-1967   DOI   ScienceOn
12 Erl, W., C. Weber, A. Zernecke, J. Neuzil, C. A. Vosseler, H. J. Kim, and P. C. Weber. 2004. Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-$\gamma$. Eur. J. Immunol. 34: 241-250   DOI   ScienceOn
13 Chinetti, G., J. C. Fruchart, and B. Staels. 2000. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49: 497-505   DOI   ScienceOn
14 Reilly, C. M., J. C. Oates, J. Suidan, M. B. Crosby, P. V. Halushka, and G. S. Gilkeson. 2001. Prostaglandin $J_2$ inhibition of mesangial cell iNOS expression. Clin. Immunol. 3: 337-345
15 Clark, R. B. 2002. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71: 388-400
16 Meade, E. A., T. M. Mcintyre, G. A. Zimmerman, and S. M. Prescott. 1999. Peroxisome proliferators enhance cyclooxygenase- 2 expression in epithelial cells. J. Biol. Chem. 274: 8328-8334   DOI   ScienceOn
17 Cunard, R., M. Ricote, D. DiCampli, D. C. Archer, D. A. Kahn, C. K. Glass, C. J. Kelly, and M. Ricote. 2002. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J. Immunol. 168: 2795-2802   DOI
18 Harris, S. G., R. S. Smith, and R. P. Phipps. 2002. 15-Deoxy- $\Delta^{12.14}-PGJ_2$ induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J. Immunol. 168: 1372-1379   DOI
19 Bureau, F., C. Desmet, D. Melotte, F. Jaspar, C. Volanti, A. Vanderplasschen, P. P. Pastoret, J. Piette, and P. Lekeux. 2002. A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: Oxidative stress-induced extracellular signal-regulated kinase activation without NFkappa B inhibition. J. Immunol. 168: 5318-5325   DOI
20 Kim, H. Y. and H. S. Kim. 2007. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-$\Delta^{12,\;14}$-prostaglandin $J_2$ in mouse peritoneal macrophages. Immunol. Cell Biol. 85: 60-67
21 Jostarndt, K., T. Rubic, H. Kuhn, M. W. Anthosen, L. Andera, N. Gellert, et al. 2004. Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-$gamma$-dependent way. Biochem. Pharmacol. 67: 841-854   DOI   ScienceOn
22 Lee, D. E., H. Y. Kim, I. H. Song, S. K. Kim, J. H. Seul, and H. S. Kim. 2004. Effect of leptin on the expression of lipopolysaccharide-induced chemokine KC mRNA in the mouse peritoneal macrophages. J. Microbiol. Biotechnol. 14: 722-729
23 Kim, H. Y., J. R. Kim, and H. S. Kim. 2006. Synergistic effect of interleukin-10 on the expression of lipopolysaccharide-induced IP-10 (CXCL-10) mRNA in mouse peritoneal macrophges. J. Microbiol. Biotechnol. 16: 1605-1612   과학기술학회마을
24 Wayman, N. S., Y. Hattori, M. C. McDonald, H. Mota-Filipe, S. Cuzzocrea, B. Pisano, P. K. Chatterjee, and C. Thiemermann. 2002. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J. 16: 1027-1040   DOI   ScienceOn
25 Straus, D. S. and C. K. Glass. 2001. Cyclopentenone prostaglandins: New insight on biological activities and cellular targets. Med. Res. Rev. 3: 185-210
26 Alleva, D. G., E. B. Johnson, F. M. Lio, S. A. Boehme, P. J. Conlon, and P. D. Crowe. 2002. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-${\gamma}$: Counter-regulatory activity by IFN-${\gamma}$. J. Leukoc. Biol. 71: 677- 685
27 Kim, H. Y., H. K. Kim, J. R. Kim, and H. S. Kim. 2005. Upregulation of LPS-induced chemokine KC expression by 15- deoxy-$\Delta^{12.14}$-prostaglandin $J_2$ in mouse peritoneal macrophages. Immunol. Cell Biol. 83: 286-293
28 Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14: 1293-1307
29 Simonin, M. A., K. Bordji, S. Boyault, A. Bianchi, E. Gouze, P. Becume, M. Dauca, P. Netter, and B. Terlain. 2002. PPAR-$\gamma$ ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am. J. Physiol. Cell Physiol. 282: 125-133   DOI
30 Cuzzocrea, S., N. S. Wayman, E. Mazzon, L. Dugo, R. Di Paola, I. Serraino, et al. 2002. The cyclopentenone prostaglandin 15-deoxy-$\Delta^{12.14}$-prostaglandin $J_2$ attenuates the development of acute and chronic inflammation. Mol. Pharmacol. 61: 997- 1007   DOI   ScienceOn
31 Straus, D. S., G. Pascual, M. Li, J. S. Welch, M. Ricote, C. H. Hsiang, L. L. Sengchanthalangsy, G. Ghosh, and C. K. Glass. 2000. 15-Deoxy-$\Delta^{12,\;14}$-prostaglandin $J_2$ inhibits multiple steps in the NF- $\kappa$B signaling pathway. Proc. Natl. Acad. Sci. USA 97: 4844-4849
32 Azuna, Y., M. Shinohara, P. L. Wang, and K. Ohura. 2001. 15- Deoxy-${\Delta}^{12.14}$-prostaglandin $J_2$ inhibits IL-10 and IL-12 production by macrophages. Biochem. Biophys. Res. Commun. 283: 344- 346   DOI   ScienceOn
33 Zhao, M. L., C. F. Brosnan, and S. C. Lee. 2004. 15-Deoxydelta (12,14)-$PGJ_2$ inhibits astrocyte IL-1 signaling: Inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. J. Neuroimmunol. 153: 132-142   DOI
34 Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-$\gamma$ agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86   DOI   ScienceOn